DDBasic Materials · Specialty ChemicalsThe 17 Wall Street analysts covering DuPont de Nemours, Inc. hold a median 12-month price target of $171 — +20.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 86 of 100 as at 1 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores DuPont de Nemours, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (100): The share count has been shrinking and the company is not leaning on new borrowing.
Growth (29): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (11): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own DuPont de Nemours, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on DD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +20.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 July 2026 | Citigroup | Maintains | Buy | $168 → $170 |
| 23 June 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 11 May 2026 | RBC Capital | Maintains | Outperform | — |
| 6 May 2026 | UBS | Maintains | Buy | — |
| 24 Apr 2026 | RBC Capital | Maintains | Outperform | — |
| 21 Apr 2026 | B of A Securities | Maintains | Neutral | — |
| 13 Apr 2026 | Citigroup | Maintains | Buy | — |
| 18 Feb 2026 | Deutsche Bank | Maintains | Buy | — |
| 17 Feb 2026 | RBC Capital | Maintains | Outperform | — |
| 12 Feb 2026 | BMO Capital | Maintains | Outperform | — |
| 11 Feb 2026 | Citigroup | Maintains | Buy | — |
| 11 Feb 2026 | Jefferies | Maintains | Buy | — |
| 11 Feb 2026 | Keybanc | Maintains | Overweight | — |
| 11 Feb 2026 | UBS | Maintains | Buy | — |
| 11 Feb 2026 | Wells Fargo | Maintains | Overweight | — |
| 21 Jan 2026 | Citigroup | Maintains | Buy | — |
| 16 Jan 2026 | JP Morgan | Maintains | Overweight | — |
| 9 Jan 2026 | Keybanc | Maintains | Overweight | — |
| 7 Jan 2026 | UBS | Maintains | Buy | — |
| 18 Dec 2025 | Mizuho | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 6% of US stocks
Cheaper than 45% of US stocks
Cheaper than 62% of US stocks
Cheaper than 27% of US stocks
Higher than 39% of US stocks
Higher than 11% of US stocks
Higher than 45% of US stocks
Higher than 72% of US stocks
Higher than 30% of US stocks
Higher than 46% of US stocks
Higher than 59% of US stocks
Higher than 40% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. DD appears on the weeks it earns a place.
The article reports that DuPont is expected to have benefited from innovation-driven investment, productivity actions, and acquisitions in Q2, despite facing cost pressures.
Why it matters — A DD watcher would care because the article previews upcoming Q2 earnings and highlights factors that may have influenced the company's quarterly performance.
Zacks Investment Research highlighted DuPont de Nemours, Inc. (DD) as one of four chemical stocks poised to beat Q2 earnings estimates, citing a recovery in end-market demand and self-help measures such as cost cuts and productivity gains.
Why it matters — The positive outlook suggests that DD's recent cost-cutting and productivity efforts, combined with improving demand, may strengthen its near-term financial performance.
The 17 Wall Street analysts covering DuPont de Nemours, Inc. have a median 12-month price target of $171, with estimates ranging from $153 to $186. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 17 analysts covering DuPont de Nemours, Inc., 14 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks DuPont de Nemours, Inc. 86 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, DuPont de Nemours, Inc. ranks 86 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (100 of 100).
No one can know that. What the data says: the median 12-month target from 17 analysts implies +20.7% from the last close, and Ticker Nerd's factor model ranks DuPont de Nemours, Inc. 86 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering DuPont de Nemours, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for DD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $153 to $186 over the next 12 months.
DuPont de Nemours, Inc. returned +62.3% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
DuPont de Nemours, Inc. is a global specialty chemicals and advanced materials company based in Wilmington, Delaware, incorporated in 2015 in its current corporate form.
The most recent item we track (Zacks Investment Research, 29 July 2026): "DuPont to Report Q2 Earnings: What's in the Offing for the Stock?". The article reports that DuPont is expected to have benefited from innovation-driven investment, productivity actions, and acquisitions in Q2, despite facing cost pressures.
DuPont de Nemours, Inc. is a global specialty chemicals and advanced materials company based in Wilmington, Delaware, incorporated in 2015 in its current corporate form. The company delivers technology-based materials, ingredients, and solutions to industrial and commercial customers across major regions, including the United States, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa. DuPont de Nemours focuses on engineered, high-performance products used in sectors such as electronics, automotive, aerospace, construction, healthcare, worker safety, water purification, and packaging. Its operations are organized into segments that broadly cover electronics and industrial applications, as well as water and protection technologies, reflecting its emphasis on differentiated, science-driven solutions for complex manufacturing and infrastructure needs. In today’s market, DuPont de Nemours plays a significant role as a materials and solutions provider within the basic materials sector and specialty chemicals industry, serving as a key supplier to global supply chains that depend on reliable, application-specific chemistries and advanced material systems.
CEO Ms. Lori D. Koch · 15,000 employees · United States · https://www.dupont.com